Skip to main content
Department of Radiation Medicine & Applied Sciences Radiation Medicine
  1. Department of Radiation Medicine & Applied Sciences
  2. Research
  3. Our Researchers
  4. Mayadev Lab
  5. Clinical Trials

Clinical Trial Highlights

  • UCSD IRB 200156, Utilization of Cervical Cancer Brachytherapy in San Diego and Imperial Counties, Principal Investigator: Jyoti Mayadev

  • UCSD IRB 200849, Investigation of Immune Correlates in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation on GOG 9929 (Prospective Phase I Trial), Co-principal investigator to use cervical cancer TR from the GOG 9929 phase I study, Principal Investigator: Jyoti Mayadev

  • UCSD IRB 800277, Quantifying Radiation Induced Vaginal Stenosis NCT05002751 Principal Investigator: Jyoti Mayadev

  • NRG GY-017: Phase I trial using anti PD-L1 (atezolizumab) as an immune primer and concurrently with extended field chemoradiotherapy for node positive locally advanced cervical cancer; National Principal Investigator Jyoti Mayadev

  • CALLA: Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) (CALLA), Principal Investigator Jyoti Mayadev

  • Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix (ARTIA-Cervix) NCT0519788, Principal Investigator Jyoti Mayadev, Funding Source: Varian Medical Systems
  • eVOLVE-Cervical (GOG-3092/ENGOT-cx19/GEICO133-C): A prospective phase III study of volrustomig versus placebo after definitive chemoradiation among women with high-risk, locally advanced cervical cancer NCT06079671, Radiation Principal Investigator, Co-Principal Investigator: Jyoti Mayadev,  Funding Source: Astra Zeneca